×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BAYRY – bayer ag s/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BAYRY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/5
12:15 pm
bayry
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
Medium
Report
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
1/29
08:30 am
bayry
Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign
Low
Report
Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign
1/27
11:00 am
bayry
Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada
Low
Report
Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada
1/27
07:30 am
bayry
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
Low
Report
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
1/26
05:46 am
bayry
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases [Yahoo! Finance]
Medium
Report
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases [Yahoo! Finance]
1/24
07:11 pm
bayry
LEGAL NOTICE TO ALL CANADIANS OUTSIDE OF QUÉBEC - NOTICE OF CLASS ACTION CERTIFICATION AND SETTLEMENT APPROVAL HEARING [Yahoo! Finance]
Medium
Report
LEGAL NOTICE TO ALL CANADIANS OUTSIDE OF QUÉBEC - NOTICE OF CLASS ACTION CERTIFICATION AND SETTLEMENT APPROVAL HEARING [Yahoo! Finance]
1/24
08:39 am
bayry
LEGAL NOTICE TO ALL CANADIANS OUTSIDE OF QUÉBEC - NOTICE OF CLASS ACTION CERTIFICATION AND SETTLEMENT APPROVAL HEARING [Globe and Mail, The (Toronto, Canada)]
Medium
Report
LEGAL NOTICE TO ALL CANADIANS OUTSIDE OF QUÉBEC - NOTICE OF CLASS ACTION CERTIFICATION AND SETTLEMENT APPROVAL HEARING [Globe and Mail, The (Toronto, Canada)]
1/22
07:48 am
bayry
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/27
Bayer more stringent in glyphosate settlement talks due to downturn [CNBC]
6.0%
3/4 Edited Transcript of BAYN.DE earnings conference call or presentation 27-Feb-20 9:00am GMT [Yahoo! Finance News] 5.7%
8/9 Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 Billion [Fortune] 4.7%
8/8 Pharmaceutical company Bayer AG acquiring BlueRock Therapeutics for US$1-billion [Toronto Globe and Mail (Ontario, Canada)] 4.2%
10/30 Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.6%
12/21 U.S. government says verdict in Bayer's Roundup case should be reversed [Reuters] 3.5%
7/15 Bayer's MRI contrast agent gets FDA approval for use in cardiac disease [Reuters] 3.3%
4/16 Exclusive: FDA may have dropped standards too far in hunt for chloroquine to fight coronavirus - sources [Reuters] 3.2%
10/30 Bayer Is Now Facing 42,700 Plaintiffs In Roundup Litigation [Investor's Business Daily] 3.0%
3/1 Chemical Weed Killer Is Compatible With Sustainability Certification In California’s Wine Industry [Forbes] 2.5%
3/4 Edited Transcript of BAYN.DE earnings conference call or presentation 27-Feb-20 9:00am GMT [Yahoo! Finance News] 5.7%
8/9 Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 Billion [Fortune] 4.7%
8/8 Pharmaceutical company Bayer AG acquiring BlueRock Therapeutics for US$1-billion [Toronto Globe and Mail (Ontario, Canada)] 4.2%
10/30 Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.6%
12/21 U.S. government says verdict in Bayer's Roundup case should be reversed [Reuters] 3.5%
7/15 Bayer's MRI contrast agent gets FDA approval for use in cardiac disease [Reuters] 3.3%
4/16 Exclusive: FDA may have dropped standards too far in hunt for chloroquine to fight coronavirus - sources [Reuters] 3.2%
10/30 Bayer Is Now Facing 42,700 Plaintiffs In Roundup Litigation [Investor's Business Daily] 3.0%
3/1 Chemical Weed Killer Is Compatible With Sustainability Certification In California’s Wine Industry [Forbes] 2.5%
TOP News Decliners
3/13
Bayer inches toward glyphosate settlement: WSJ [Reuters]
-10.9%
3/7 Bayer Investor Sues Top Officials for ‘Disastrous’ Monsanto Deal [Yahoo! Finance News] -9.0%
4/15 Proxy advisers split over endorsing Bayer management at AGM [Reuters] -4.6%
2/27 Bayer aims for 7%-9.6% profit growth in 2020 [Reuters] -4.1%
7/29 More Brazil farmers challenge Bayer soy patent [Seeking Alpha] -4.0%
1/24 UPDATE 1-Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown [Reuters] -3.7%
3/2 Monsanto worker's morbid obesity not a disability- 5th Circuit [Reuters] -3.4%
2/15 Bayer Jury Awards Farmer $15 Million for Dicamba Crop Damage [Yahoo! Finance News] -3.1%
4/28 Bayer board wins back shareholder support as weed-killer talks continue [Toronto Globe and Mail (Ontario, Canada)] -3.0%
5/22 Judge taps Feinberg as mediator in Bayer Roundup settlement talks [Seeking Alpha] -2.9%
3/7 Bayer Investor Sues Top Officials for ‘Disastrous’ Monsanto Deal [Yahoo! Finance News] -9.0%
4/15 Proxy advisers split over endorsing Bayer management at AGM [Reuters] -4.6%
2/27 Bayer aims for 7%-9.6% profit growth in 2020 [Reuters] -4.1%
7/29 More Brazil farmers challenge Bayer soy patent [Seeking Alpha] -4.0%
1/24 UPDATE 1-Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown [Reuters] -3.7%
3/2 Monsanto worker's morbid obesity not a disability- 5th Circuit [Reuters] -3.4%
2/15 Bayer Jury Awards Farmer $15 Million for Dicamba Crop Damage [Yahoo! Finance News] -3.1%
4/28 Bayer board wins back shareholder support as weed-killer talks continue [Toronto Globe and Mail (Ontario, Canada)] -3.0%
5/22 Judge taps Feinberg as mediator in Bayer Roundup settlement talks [Seeking Alpha] -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: